Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 70 (1-2), 21-28
- https://doi.org/10.1016/s0168-3659(00)00313-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Multivesicular Liposome (DepoFoam) Technology for the Sustained Delivery of Insulin-Like Growth Factor-I (IGF-I)Journal of Pharmaceutical Sciences, 1998
- Improving protein therapeutics with sustained-release formulationsNature Biotechnology, 1998
- Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effectJournal of Controlled Release, 1997
- One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetateAdvanced Drug Delivery Reviews, 1997
- The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibilityJournal of Microencapsulation, 1997
- A month–long effect from a single injection of microencapsulated human growth hormoneNature Medicine, 1996
- Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheresJournal of Controlled Release, 1995
- Clinical Uses of Insulin-like Growth Factor IAnnals of Internal Medicine, 1994
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Insulin-Like Growth Factors/Somatomedins: Structure, Secretion, Biological Actions and Physiological RoleHormone Research, 1986